Chronic Gout Drugs Could Receive Accelerated Approval, Advisory Cmte. Says
Chronic gout drugs could receive accelerated approval based on surrogate endpoints, FDA's Arthritis Advisory Committee concluded June 2
Chronic gout drugs could receive accelerated approval based on surrogate endpoints, FDA's Arthritis Advisory Committee concluded June 2